Integra Lifesciences Holdings (IART) EBT Margin (2009 - 2026)

Integra Lifesciences Holdings has disclosed EBT Margin across 18 years of filings, most recently posting 1.13% for Q2 2026.

• In Q2 2026, EBT Margin rose 12889.0% year-over-year to 1.13%; the TTM figure through Jun 2026 stood at 0.01% (up 3445.0% YoY), while the FY2025 annual figure was 34.46%, down 3333.0% from the prior year.
• EBT Margin came in at 1.13% for Q2 2026 at Integra Lifesciences Holdings, up from 0.61% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 16.13% in Q4 2022 to a low of 127.75% in Q2 2025.
• Average EBT Margin over 5 years is 3.63%, with a median of 1.07% recorded in 2023.
• Year-over-year, EBT Margin sank 12412 bps in 2025 and jumped 12889 bps in 2026.
• Over 5 years, EBT Margin stood at 16.13% in 2022, then slumped by 55 bps to 7.27% in 2023, then fell by 30 bps to 5.09% in 2024, then tumbled by 81 bps to 0.99% in 2025, then gained by 14 bps to 1.13% in 2026.
• Per Business Quant data, the three most recent EBT Margin figures were 1.13% in Q2 2026, 0.61% in Q1 2026, and 0.99% in Q4 2025.